Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy

May 2008
Indian Journal of Ophthalmology;May2008, Vol. 56 Issue 3, p259
Academic Journal
No abstract available.


Related Articles

  • Response to Carifi et al.'s Letter. Yang, Chang-Sue; Hung, Kuo-Che; Huang, Yi-Ming; Hsu, Wen-Ming // Journal of Ocular Pharmacology & Therapeutics;May2014, Vol. 30 Issue 4, p304 

    Chang-Sue Yang, Kuo-Che Hung,Yi-Ming Huang and Wen-Ming Hsu respond to a letter to the editor submitted in response to their article "Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy", which appeared in a previous...

  • Intravitreal Anti-VEGF Treatment as Adjunctive Treatment in the Management of Diabetic Retinopathy. Carifi, Gianluca; Zygoura, Vasiliki; Kopsachilis, Nikolaos // Journal of Ocular Pharmacology & Therapeutics;May2014, Vol. 30 Issue 4, p303 

    A letter to the editor is presented in response to the article "Intravitreal Bevacizumab (Avastin) and Panretinal Photocoagulation in the Treatment of High-Risk Proliferative Diabetic Retinopathy" by C. S. Yang, K. C. Hung, Y. M. Huang et al., which appeared in a previous issue of the journal.

  • Bevacizumab.  // Reactions Weekly;1/21/2012, Issue 1385, p11 

    The article describes the cases of 25 patients who developed tractional retinal detachment (TRD) after treatment with intravitreal bevacizumab prior to vitrectomy for proliferative diabetic retinopathy.

  • Tratamento da retinopatia por radiação com injeção intravítrea de bevacizumab (Avastin): relato de caso. LAVEZZO, MARCELO MENDES; HOKAZONO, KENZO; TAKAHASHI, WALTER YUKIHIKO // Arquivos Brasileiros de Oftalmologia;2010, Vol. 73 Issue 4, p373 

    Purpose: To report a case of radiation retinopathy treatment with intravitreal injection of bevacizumab (Avastin®) in a patient undergoing radiotherapy for lymphoma in the right orbit. Patient of 55 years-old male, diabetic, diagnosed with an orbital MALT lymphoma three years ago, treated...

  • Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin). Kenawy, N.; Groenwald, C.; Damato, B. // Eye;Jun2007, Vol. 21 Issue 6, p893 

    A letter to the editor that provides information about a case study on the treatment of vasoproliferative tumor with intravitreal bevacizumab (Avastin) is presented.

  • Treating proliferative diabetic retinopathy with off-label drug shows promise. Avery, Robert // Ophthalmology Times;3/1/2007, Vol. 32 Issue 5, p50 

    The article reports that a clinical study of the use of intravitreal injection of off-label bevacizumab to treat proliferative diabetic retinopathy has showed promise in the prevention of neovascularization regression. According to the study of Dr. Robert Avery, the intravitreal injection of...

  • Rapid regression of disc neovascularization in a patient with proliferative diabetic retinopathy following adjunctive intravitreal bevacizumab. Bakri, S. J.; Donaldson, M. J.; Link, T. P. // Eye;Dec2006, Vol. 20 Issue 12, p1474 

    A letter to the editor is presented in response to the article "Rapid Regression of Disc Neovascularization in a Patient with Proliferative Diabetic Retinopathy Following Adjunctive Intravitreal Bevacizumab," published in the previous issue.

  • Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity. Raizada, Seemant; Al Kandari, Jamal; Al Foudari, Ahmad // Middle East African Journal of Ophthalmology;Apr-Jun2011, Vol. 18 Issue 2, p196 

    A letter to the editor is presented in response to the article on the early experience with intravitreal bevacizumab and laser treatment for retinopathy of maturity by AE Ahmed and colleagues.

  • Vitreous, Choroid, and Retina.  // Current Medical Literature: Ophthalmology;2009, Vol. 19 Issue 2, p59 

    The section presents several articles related to choroid, vitreous, and retina published in various medical journals. These include the epidemiology of progression of pure geographic atrophy, a prospective randomized study on the role of combined cataract surgery and intravitreal bevacizumab...

  • Bevacizumab.  // Reactions Weekly;9/5/2009, Issue 1268, p10 

    The article describes the case of a 63-year-old man who acquired dendritic keratitis. The patient developed the said condition after intravitreal administration of bevacizumab for proliferative diabetic retinopathy. The patient was treated with topical acyclovir. After two weeks of treatment,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics